Oral ingestion of Verisol collagen peptides lead to a pronounced, statistically significant reduction of eye wrinkle volume. This is the result of a recently published study by the University of Kiel Germany focusing on the effect of these Bioactive Collagen Peptides (BCP) on human skin conditions.
“There is a direct impact on dermal extracellular matrix turnover,” stated Dr Stephan Hausmanns, vice president Business Unit Health & Nutrition. “This is clearly demonstrated by a significant increase in collagen and elastin synthesis, with the result of statistically significant wrinkle reduction after only 4, and even more pronounced after 8 weeks of treatment. In simple words: the participants looked considerably younger after the treatment.”
This study completes the results from a previous Verisol study proving the effect of Verisol on skin elasticity. Together the results of the two studies provide a sound scientific foundation for the development of innovative nutricosmetics, which are used by a growing consumer group to complement topical applications and follow a more holistic approach to skin care.
After 4 weeks of treatment the BCP group showed a statistically significantly reduced eye wrinkle volume of more than 7.2% on average. This positive effect was more pronounced after 8 weeks of intake (20.1%).
Four weeks after the last product intake (4-week regression phase), the BCP treatment group still showed a statistically significant decrease in eye wrinkle volume of 11.5%.
Pro-collagen type I content was increased by 65%, elastin by 18% and fibrillin by 6% after 8 weeks of BCP treatment.
